
Plant Health Care PLC
LSE:PHC

Net Margin
Plant Health Care PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
Plant Health Care PLC
LSE:PHC
|
30.5m GBP |
-36%
|
|
US |
![]() |
Corteva Inc
NYSE:CTVA
|
50.2B USD |
7%
|
|
CA |
![]() |
Nutrien Ltd
TSX:NTR
|
40.2B CAD |
2%
|
|
US |
![]() |
CF Industries Holdings Inc
NYSE:CF
|
15.4B USD |
22%
|
|
SA |
![]() |
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR |
30%
|
|
CN |
![]() |
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
102.1B CNY |
31%
|
|
CL |
![]() |
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
11.9B USD |
13%
|
|
US |
![]() |
Mosaic Co
NYSE:MOS
|
11.7B USD |
3%
|
|
RU |
![]() |
PhosAgro PAO
MOEX:PHOR
|
832.7B RUB |
21%
|
|
CN |
![]() |
Zangge Mining Co Ltd
SZSE:000408
|
74.4B CNY |
88%
|
|
NO |
![]() |
Yara International ASA
OSE:YAR
|
98.9B NOK |
5%
|
Plant Health Care PLC
Glance View
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Raleigh, North Carolina and currently employs 45 full-time employees. The company went IPO on 2004-07-06. The firm's segments include Americas, Mexico, and Rest of World. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. Its biological products help growers to protect their crops from stress and diseases. Its lead product, Harpin ab, is a recombinant protein developed from the naturally occurring Harpin proteins, which act as a biostimulant, promoting the yield and quality of crops. The company is also focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The company is developing six lead products from three platforms, including Innatus 3G platform, which targets growth and disease resistance; T-Rex 3G platform, which targets nematode defense, while the Y-Max 3G platform delivers increased yield and growth.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Plant Health Care PLC's most recent financial statements, the company has Net Margin of -35.7%.